Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: Common pathway of gene regulation

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2089-2093

  Furuya, Yuzo ^a   Ohta, Sho ^a   Ito, Haruo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Androgen independent; Apoptosis; Prostatic cancer; Topoisomerase inhibitors

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CYCLIN DEPENDENT KINASE INHIBITOR; DNA FRAGMENT; DNA TOPOISOMERASE; ENZYME INHIBITOR; ETOPOSIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; RAT;

ANDROGENS; ANIMALS; APOPTOSIS; CAMPTOTHECIN; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA FRAGMENTATION; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; HUMANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROSTATIC NEOPLASMS; RATS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030763039     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Catalona WJ and Scott WW: Carcinoma of the prostate. J Urol 119: 1-8, 1978.
2. Kyprianou N, English HF and Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748-3753, 1990.
3. Schulze H, Isaacs JT and Senge T: Inability of complete androgen blockade to increase survival of patients with advanced prostate cancer as compared to standard hormonal therapy. J Urol 137: 909-911, 1987.
4. Kyprianou N and Isaacs JT: "Thymineless" death in androgen-independent prostatic cancer cells, Biochem Biophys Res Commun 165:73-81, 1989.
5. Furuya Y and Shimazaki J: Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal, Anticancer Res 16: 2613-2618, 1996.
6. Furuya Y, Ohta S and Shimazaki J: Induction of apoptosis in androgen-independent mouse mammary cell line by 1,25-dihydroxyvitamin D3. Int J Cancer 68: 143-148, 1996.
7. Furuya Y, Ito H, Ohta S and Shimazaki J: Induction of apoptosis in androgen-independent mouse cell line by transforming growth factor-β1. J Exp Therapeu Oncol 1996, in press.
8. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-375, 1989.
9. Evans DL and Dive C: Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133-9, 1993.
10. Barry MA, Reynolds JE and Eastman A: Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53: 2349-2357, 1993.
11. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T and Kizaki H: Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim Biophys Acta 1175: 147-54, 1993.
12. Smith PJ, Soues S, Gottlieb T, Falk SJ, Watson JV, Osborne RJ and Bleehen NM: Etoposide-induced cell cycle delay and arrest- dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer 70: 914-21, 1994.
13. Isaacs JT, Isaacs WB, Feitz FJ and Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic ability of prostatic cancer. Prostate 9: 261-281, 1989.
14. Iizumi T, Yazaki T, Kanon S, Kondo I and Koiso K: Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 137: 1304-1306, 1987.
15. Furuya Y, Sato N, Akakura K, Ichikawa T, Suzuki N, Sato R and Shimazaki J: Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2). Cancer Res 50: 4979-83, 1990.
16. Furuya Y, Shirasawa H, Sato N, Watabe Y, Simizu B and Shimazaki J: Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumor (Shionogi Carcinoma 115). J Steroid Biochem Molec Biol 42: 569-574, 1992.
17. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT and Davidson NE: Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54: 5280-3, 1994.
18. Furuya Y, Isaacs JT and Shimazaki J: Induction of programmed death/apoptosis in androgen-dependent mouse mammary tumor cell line (Shionogi carcinoma 115)by androgen withdrawal. Jpn J Cancer Res 86: 1159-1165, 1995.
19. Ueda N and Shah SV: Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 90: 2593-2597, 1992.
20. Vindelov L, Christensen I and Nissen N: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
21. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Furuya Y and Isaacs JT: Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133: 2660-6, 1993.
23. Furuya Y and Isaacs JT: Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation. Prostate 25: 301-9, 1994.
24. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P and Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9: 3473-3481, 1989.
25. Kyprianou N and Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3: 1515-1522, 1989.
26. Sokolova IA, Cowan KH and Schneider E: Ca2+/Mg2+-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochim Biophys Acta 1266: 135-142, 1995.
27. Furuya Y, Un XS, Walsh JC, Nelson WG and Isaacs JT: Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136: 1898-1906, 1995.
28. Furuya Y, Krajewski S, Epstein JI, Reed JC and Isaacs JT: Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res 2: 389-398, 1995.